Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1. - Yergey AL; Blank PS; Cologna SM; Backlund PS; Porter FD; Darling AJ (PloS one, 2018)